News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Study: Altering reelin levels a possible new treatment for MS

August 14, 2020

Researchers suggest that reducing immune cells’ ability to accumulate and cause inflammation by altering reelin levels could represent a new strategy for treating patients with MS.
Learn more

Special Needs Group launches offer to support MS Focus

August 12, 2020

The organization will donate 10 percent to MS Focus for every Soothie Cushion they sell. This new, ongoing initiative was launched in July.
Learn more

MS mental fatigue linked to slower response to high mental activity

July 30, 2020

The findings suggest significant differences between the two groups in use of brain resources in response to increased mental activity. 
Learn more

MS Focus joins effort to preserve copay help for those with chronic diseases

July 28, 2020

MS Focus joined more than 100 organizations to oppose a provision that would increase barriers to access of care and put individuals struggling with chronic and debilitating diseases at risk
Learn more

Study: Higher severe COVID-19 risk for patients on Ocrevus, Rituxan

July 24, 2020

For most patients with MS, the benefits of remaining on their therapy still outweighs the risk. Individual treatment decisions need to be made between the person with MS and their healthcare team.
Learn more

Survey: Alternative medicine is widespread among people with MS

June 30, 2020

The survey found patients are nine times more likely to talk with their neurologist about the use of alternative therapies than patients in a similar survey conducted in 2001.
Learn more

Study finds no link between DMTs and Covid-19 severity

June 26, 2020

Researchers found risk factors for severe forms of COVID-19 were neurological disability, age, and obesity, but no link was found between disease-modifying therapies exposure and COVID-19 severity.
Learn more

Research on MS, gait to lead to more effective fall prevention

June 23, 2020

Researchers: The study leads to the understanding that step length and foot landing angle are two significant factors for maintaining body dynamic balance in people with MS.
Learn more

Researchers seek participants for lockdown fall-risk study

June 22, 2020

The purpose of the study is to explore the prevalence and circumstances of falls and fall-related injuries.
Learn more

Study: Altering reelin levels a possible new treatment for MS

August 14, 2020

Researchers suggest that reducing immune cells’ ability to accumulate and cause inflammation by altering reelin levels could represent a new strategy for treating patients with MS.
Learn more

Special Needs Group launches offer to support MS Focus

August 12, 2020

The organization will donate 10 percent to MS Focus for every Soothie Cushion they sell. This new, ongoing initiative was launched in July.
Learn more

MS mental fatigue linked to slower response to high mental activity

July 30, 2020

The findings suggest significant differences between the two groups in use of brain resources in response to increased mental activity. 
Learn more

MS Focus joins effort to preserve copay help for those with chronic diseases

July 28, 2020

MS Focus joined more than 100 organizations to oppose a provision that would increase barriers to access of care and put individuals struggling with chronic and debilitating diseases at risk
Learn more

Study: Higher severe COVID-19 risk for patients on Ocrevus, Rituxan

July 24, 2020

For most patients with MS, the benefits of remaining on their therapy still outweighs the risk. Individual treatment decisions need to be made between the person with MS and their healthcare team.
Learn more

Survey: Alternative medicine is widespread among people with MS

June 30, 2020

The survey found patients are nine times more likely to talk with their neurologist about the use of alternative therapies than patients in a similar survey conducted in 2001.
Learn more

Study finds no link between DMTs and Covid-19 severity

June 26, 2020

Researchers found risk factors for severe forms of COVID-19 were neurological disability, age, and obesity, but no link was found between disease-modifying therapies exposure and COVID-19 severity.
Learn more

Research on MS, gait to lead to more effective fall prevention

June 23, 2020

Researchers: The study leads to the understanding that step length and foot landing angle are two significant factors for maintaining body dynamic balance in people with MS.
Learn more

Researchers seek participants for lockdown fall-risk study

June 22, 2020

The purpose of the study is to explore the prevalence and circumstances of falls and fall-related injuries.
Learn more

Experts analyze options for treating MS-related cognitive impairment

June 18, 2020

To date, none of the available medications or disease-modifying therapies for MS are indicated for the treatment of cognitive deficits.
Learn more

Study: Favorable outcomes reported for COVID-19 patients with MS on Teriflunomide

June 17, 2020

The authors state future studies are necessary to understand what role, if any, teriflunomide therapy may play in COVID-19 infection.
Learn more

Rebif label now includes pregnancy outcomes, lactation information

June 05, 2020

Now, new, limited, data shows the presence of interferon beta-1a products in human milk at low levels.
Learn more

New oral treatment, Zeposia, available for relapsing forms of MS

June 02, 2020

The Zeposia 360 Support program will facilitate access to Zeposia for appropriate patients with MS.
Learn more

Study: MS risk higher for people living in urban areas

May 27, 2020

Researchers showed the MS risk was 29 percent higher among those residing in more urbanized areas.
Learn more

Blood test may help predict whose MS will get worse

May 26, 2020

The blood test looks for a nerve protein that can be detected in the blood when nerve cells die.
Learn more

Mindfulness training shows promise for people with MS

May 20, 2020

One of the reasons that mindfulness training is so promising is because it is an easily accessible treatment for all patients.
Learn more

Animal study shows human brain cells repair damage in MS

May 20, 2020

Study provides one of the final pieces of evidence necessary to advance treatment strategy to clinical trials.
Learn more

Study: Local inflammatory cells are characteristic for advanced MS

May 18, 2020

These new findings support the idea that during the late phase of MS, the disease is happening entirely inside the brain.
Learn more


Show More News